MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

07 Aug 2023 Evaluate
The Total revenue for the quarter ended June 2023 of  Rs. 115.82 millions remain, more or less, the same.The Company's Net profit for the June 2023 quarter have declined marginally to Rs. 2.57  millions as against Rs. 3.15 millions reported during the corresponding quarter ended.A decline of 46.00 millions was observed in the OP in the quarter ended June 2023 from 47.83 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 115.82 112.63 2.83 115.82 112.63 2.83 516.22 513.91 0.45
Other Income 0.00 0.01 0.00 0.00 0.01 0.00 0.36 0.92 -60.87
PBIDT 46.00 47.83 -3.83 46.00 47.83 -3.83 215.23 159.08 35.30
Interest 19.47 17.63 10.44 19.47 17.63 10.44 76.51 39.93 91.61
PBDT 26.53 30.20 -12.15 26.53 30.20 -12.15 138.72 119.15 16.42
Depreciation 22.85 23.35 -2.14 22.85 23.35 -2.14 92.66 74.41 24.53
PBT 3.68 6.85 -46.28 3.68 6.85 -46.28 46.06 44.74 2.95
TAX 1.11 3.70 -70.00 1.11 3.70 -70.00 19.71 22.71 -13.21
Deferred Tax -0.61 2.56 -123.83 -0.61 2.56 -123.83 9.41 15.12 -37.76
PAT 2.57 3.15 -18.41 2.57 3.15 -18.41 26.35 22.03 19.61
Equity 149.04 148.77 0.18 149.04 148.77 0.18 149.03 142.64 4.48
PBIDTM(%) 39.72 42.47 -6.47 39.72 42.47 -6.47 41.69 30.95 34.69
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..